BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23350250)

  • 1. Seroprevalence study in Vojvodina (Serbia) following 2009 pandemic influenza A(H1N1)V.
    Petrović V; Reguljev Z; Nedeljković J; Ristić M
    Srp Arh Celok Lek; 2012; 140(11-12):751-5. PubMed ID: 23350250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.
    Maltezou HC; Katerelos P; Mavrouli M; Lourida A; Routsias JG; Spanakis N; Maragos A; Tedoma A; Bassiakos Y; Koratzanis G; Mantagos S; Metallidis S; Katragkou A; Nikolaidis P; Roilides E; Theodoridou M; Tsakris A
    Vaccine; 2011 Sep; 29(38):6664-9. PubMed ID: 21762749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.
    Poeppl W; Poeppl G; Hunger M; Tobudic S; Winkler H; Faas A; Mooseder G; Burgmann H
    J Med Virol; 2012 Sep; 84(9):1331-4. PubMed ID: 22825809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of seasonal and pandemic influenza a in Kuala Lumpur, Malaysia in 2008-2010.
    Sam IC; Shaw R; Chan YF; Hooi PS; Hurt AC; Barr IG
    J Med Virol; 2013 Aug; 85(8):1420-5. PubMed ID: 23765779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.
    Tsai TF; Pedotti P; Hilbert A; Lindert K; Hohenboken M; Borkowski A; Groth N; da Silva LJ; Kyaw MH
    Euro Surveill; 2010 Jul; 15(30):. PubMed ID: 20684814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran.
    Moghadami M; Moattari A; Tabatabaee HR; Mirahmadizadeh A; Rezaianzadeh A; Hasanzadeh J; Ebrahimi M; Zamiri N; Alborzi A; Bagheri Lankarani K
    Iran J Immunol; 2010 Mar; 7(1):39-48. PubMed ID: 20371918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological features of 2009 pandemic H1N1 influenza differ slightly according to seroprevalence status during the second wave in the general population in México.
    Elizondo-Montemayor L; Hernández-Torre M; Ugalde-Casas PA; Santos-Guzmán J; Serrano-González M; Gutiérrez NG; Lam-Franco L; Tamargo-Barrera D; Martínez U; Bustamante-Careaga H; Alvarez MM; Schultz-Cherry S
    Respir Care; 2012 Oct; 57(10):1586-93. PubMed ID: 22418453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009.
    Waalen K; Kilander A; Dudman SG; Krogh GH; Aune T; Hungnes O
    Euro Surveill; 2010 Aug; 15(31):. PubMed ID: 20738992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serologic survey on pandemic influenza A (H1N1) virus among aged ≥ 3 years population from Jiangsu province in 2009, China].
    Tang FY; Zu RQ; Li L; Qi X; Ji H; Wu B; Xu K; Fu JG; Qin YF; Deng F; Yang HT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):489-93. PubMed ID: 21163021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].
    Ertek M; Sevencan F; Kalaycıoğlu H; Gözalan A; Simşek C; Culha G; Dorman V; Ozlü A; Arıkan F; Aktaş D; Akın L; Korukluoğlu G; Sevindi DF
    Mikrobiyol Bul; 2011 Oct; 45(4):684-96. PubMed ID: 22090299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
    Deng Y; Pang XH; Yang P; Shi WX; Tian LL; Liu BW; Li S; Cui SJ; Li Y; Lu GL; Zhang L; Zhang X; Liu B; Seale H; Huang F; Wang QY
    Epidemiol Infect; 2011 Jan; 139(1):52-8. PubMed ID: 20854713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.
    Kumar S; Fan J; Melzer-Lange M; Trost J; Havens PL; Willoughby RE; Chusid MJ; Henrickson KJ
    Pediatr Emerg Care; 2011 Sep; 27(9):804-7. PubMed ID: 21878831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A survey on serological epidemiology of influenza A (H1N1) 2009 in Beijing].
    Yang P; Huang F; Shi WX; Lu GL; Tian LL; Cui SJ; Zhang X; Li S; Liu BW; Deng Y; Pang XH; Wang QY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):485-8. PubMed ID: 21163020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.